[1] Seto WK,Lo YR,Pawlotsky JM,et al.Chronic hepatitis B virus infection. Lancet,2018,392(10161):2313-2324. [2] Qu EZ,Zhang YC,Li ZY,et al.Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. J Ultrasound Med,2014,33(11):1971-1977. [3] Mok SRS,Diehl DL,Johal AS,et al.A prospective pilot comparison of wet and dry heparinized suction for EUS-guided liver biopsy (with videos). Gastrointest Endosc,2018,88(6):919-925. [4] Nahon P,Layese R,Bourcier V,et al.Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients With cirrhosis included in surveillance programs. Gastroenterology,2018,155(5):1436-1450,e6. [5] Borro P,Dellepiane SG,Pellicano R,et al.Quantification of ultrasound imaging in the staging of hepatic fibrosis. Panminerva Med,2018,60(2):44-51. [6] Liu J,Ren W,Ai H, et al.Acoustic structure quantification versus point shear wave speed measurement for the assessment of liver fibrosis in viral hepatitis B. Ultrasound Med Biol,2018,44(6):1177-1186. [7] Moustafa EF,Makhlouf N,Hassany SM,et al.Non-invasive assessment of liver fibrosis in patients with hepatitis C:Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy. Arab J Gastroenterol, 2017,18(1):6-12. [8] Seitz K,Piscaglia F.Ultrasound:the only “one stop shop” for modern management of liver disease. Ultraschall Med,2013,34(6):500-503. [9] 中华医学会肝病学分会; 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):389-400. [10] Kotha S,Neong S,Patel K.Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Rev Mol Diagn,2018,18(8):713-722. [11] Sagnelli E,Stroffolini T,Sagnelli C,et al.Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. Eur J Gastroenterol Hepatol,2018,30(6):676-681. [12] Ganne-Carrié N,Chaffaut C,Bourcier V,et al.Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis. J Hepatol,2018,69(6):1274-1283. [13] 刘保池. 肝硬化的手术与细胞治疗. 中华消化病与影像杂志(电子版),2018,8(5):193-196. [14] 祁小龙. 肝硬化门静脉高压无创时代: 我们如何把握. 中华肝脏病杂志,2018,26(4):241-244. [15] Lin Z,Liang J,Zhu J,et al.Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B. Eur J Gastroenterol Hepatol,2018,30(2):217-225. [16] Aubé C,Bazeries P,Lebigot J,et al.Liver fibrosis,cirrhosis,and cirrhosis-related nodules:Imaging diagnosis and surveillance. Diagn Interv Imaging,2017,98(6):455-468. [17] Iranpour P,Lall C,Houshyar R,et al.Altered Doppler flow patterns in cirrhosis patients:an overview. Ultrasonography,2016,35(1): 3-12. [18] 魏华,马旭艳. 彩色多普勒超声半定量评分对早期乙型肝炎肝硬化的诊断价值. 实用肝脏病杂志,2017,20(1):78-80. [19] Soker G,Bahadir Ozturk A,Gulek B,et al.Doppler ultrasonography helps discriminate between cirrhotic and non-cirrhotic patients with viral B and C hepatitis. Diagn Interv Imaging,2016,97(3):339-345. [20] 芦金飞,陈建国,郑笑娟,等. 彩色多普勒超声半定量评分对早期慢性乙型肝炎肝硬化的诊断价值. 中华医院感染学杂志,2015,25(4):871-873. |